Children’s Hospital Los Angeles to Launch $5.3 million NIH Study for First Clinical Trial for Down Syndrome Regression Disorder

LOS ANGELES–(BUSINESS WIRE)– #childrenshealth–Children’s Hospital Los Angeles (CHLA) has launched the first clinical trial for Down syndrome regression disorder (DSRD), a rare and debilitating condition that affects adolescents and young adults with Down syndrome. The study—a collaboration with the University of Colorado and Children’s Hospital Colorado—is funded by a five-year, $5.3 million grant from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute for Child Health and Human
Click here to view original post